A23V 2250/7052
Vitamin b6
Official title: Vitamin B6
A23V2250/7052 (Vitamin b6) appears on 16 US grants and 26 published applications in this corpus.
Search patents in A23V- Granted patents
- 16
- Published applications
- 26
- Assignees
- 11
- Inventors
- 31
- Latest grant
- 6 Jun 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 1 | 0 |
| 2018 | 1 | 5 |
| 2019 | 0 | 7 |
| 2020 | 3 | 1 |
| 2021 | 4 | 2 |
| 2022 | 4 | 2 |
| 2023 | 2 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Deuterated caffeine and uses thereof6 Jun 2023US 11,666,073 B2Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof10 Jan 2023US 11,547,127 B2Lennham Pharmaceuticals, Inc.
- Vitamin supplement compositions with enhanced bioavailability3 May 2022US 11,318,150 B1
- Multivitamin extrudates22 Mar 2022US 11,278,046 B2Dsm IP Assets B.V.
- Antioxidant-enriched multivitamin composition and methods of use25 Jan 2022US 11,229,230 B2Callion Pharma, LLC
- Deuterated caffeine and uses thereof7 Aug 2025US 2025/0248424 A1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof29 Aug 2024US 2024/0284942 A1Lannham Pharmaceuticals, Inc,
- Deuterated caffeine and uses thereof23 Nov 2023US 2023/0371555 A1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof11 Aug 2022US 2022/0248720 A1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof21 Jul 2022US 2022/0225642 A1Lennham Pharmaceuticals, Inc.
Most cited
By later US patents
- Vitamin supplement compositions with enhanced bioavailability5US 10,617,700 B12020
- Composition for countering the effects of alcohol consumption5US 8,507,015 B2Lquid Innovations, LLC · 2013
- Deuterated caffeine and uses thereof4US 10,582,716 B1Lennham Pharmaceuticals, Inc. · 2020
- Deuterated caffeine and uses thereof3US 10,765,130 B1Lennham Pharmaceuticals, Inc. · 2020
- Infant formulas having vitamin complexes with enhanced bioavailability2US 11,122,833 B12021